Signaling through the prostaglandin I2 receptor IP protects against respiratory syncytial virus-induced illness

Journal of Virology

Volumn 78, Issue 19, 2004, Pages 10303-10309

  Hashimoto, Koichi ^a,b   Graham, Barney S ^c   Geraci, Mark W ^d   FitzGerald, Garret A ^e   Egan, Karine ^e   Zhou, Weisong ^a   Goleniewska, Kasia ^a   O'Neal, Jamye F ^a   Morrow, Jason D ^a   Durbin, Russell K ^f   Wright, Peter F ^a   Collins, Robert D ^a   Suzutani, Tatsuo ^b   Peebles Jr , R Stokes ^a,g  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^d UNIVERSITY OF COLORADO   (United States)

^e UNIVERSITY OF PENNSYLVANIA   (United States)

^f OHIO STATE UNIVERSITY   (United States)

^g VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; PROSTACYCLIN; PROSTACYCLIN RECEPTOR; PROSTACYCLIN SYNTHASE; PROSTAGLANDIN I2 RECEPTOR IP; UNCLASSIFIED DRUG; 2,3 DINOR 6 KETOPROSTAGLANDIN F1ALPHA; 2,3-DINOR-6-KETOPROSTAGLANDIN F1ALPHA; 6 OXOPROSTAGLANDIN F1 ALPHA; ALPHA INTERFERON; BETA INTERFERON; CYTOCHROME P450; DRUG DERIVATIVE; ISOMERASE; SURFACTANT PROTEIN A; SURFACTANT PROTEIN B; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; ARTICLE; BRONCHUS MUCOSA; CELL PROTECTION; CLEARANCE; CONTROLLED STUDY; FEMALE; GENE TARGETING; HUMAN; HUMAN CELL; LUNG; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SIGNAL TRANSDUCTION; TRANSGENIC ANIMAL; VIRUS INFECTION; VIRUS REPLICATION; WEIGHT REDUCTION; ANIMAL; BIOSYNTHESIS; BLOOD; CHEMISTRY; COMPARATIVE STUDY; DISEASE MODEL; GENE DELETION; GENETICS; GROWTH, DEVELOPMENT AND AGING; IMMUNOLOGY; LUNG EDEMA; MALE; METABOLISM; PATHOGENICITY; PATHOLOGY; PATHOPHYSIOLOGY; RESPIRATORY TRACT MUCOSA; TRANSGENIC MOUSE; URINE; VIROLOGY;

6-KETOPROSTAGLANDIN F1 ALPHA; ANIMALS; ANTIBODIES, VIRAL; CYTOCHROME P-450 ENZYME SYSTEM; DISEASE MODELS, ANIMAL; EPOPROSTENOL; FEMALE; GENE DELETION; INTERFERON TYPE II; INTERFERON-ALPHA; INTERFERON-BETA; INTRAMOLECULAR OXIDOREDUCTASES; LUNG; MALE; MICE; MICE, TRANSGENIC; PULMONARY EDEMA; PULMONARY SURFACTANT-ASSOCIATED PROTEIN A; PULMONARY SURFACTANT-ASSOCIATED PROTEIN B; RECEPTORS, EPOPROSTENOL; RESPIRATORY MUCOSA; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; SIGNAL TRANSDUCTION; WEIGHT LOSS;

EID: 4544359258     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.78.19.10303-10309.2004     Document Type: Article

References (26)

1. American Academy of Pediatrics Committee on Infectious Diseases and Committee of Fetus and Newborn. 1998. Prevention of respiratory syncytial virus infections: indications for the use of palivizumab and update on the use of RSV-IGIV. Pediatrics 102:1211-1216.
2. Aung, S., J. A. Rutigliano, and B. S. Graham. 2001. Alternative mechanisms of respiratory syncytial virus clearance in perforin knockout mice lead to enhanced disease. J. Virol. 75:9918-9924.
3. Breyer, R. M., C. K. Bagdassarian, S. A. Myers, and M. D. Breyer. 2001. Prostanoid receptors: subtypes and signaling. Annu. Rev. Pharmacol. Toxicol. 41:661-690.
4. Breyer, R. M., C. R. Kennedy, Y. Zhang, and M. D. Breyer. 2000. Structure-function analyses of eicosanoid receptors. Physiologic and therapeutic implications. Ann. N. Y. Acad. Sci. 905:221-231.
5. Cheng, Y., S. C. Austin, B. Rocca, B. H. Koller, T. M. Coffman, T. Grosser, J. A. Lawson, and G. A. Fitzgerald. 2002. Role of prostacyclin in the cardiovascular response to thromboxane A2. Science 296:539-541.
6. Costantini, V., A. Giampietri, M. Allegrucci, G. Agnelli, G. G. Nenci, and M. C. Fioretti. 1991. Mechanisms of the antimetastatic activity of stable prostacyclin analogues: modulation of host immunocompetence. Adv. Prostaglandin Thromboxane Leukot. Res. 21B:917-920.
7. Daniel, V. C., T. A. Minton, N. J. Brown, J. H. Nadeau, and J. D. Morrow. 1994. Simplified assay for the quantification of 2,3-dinor-6-keto-prostaglandin F1 alpha by gas chromatography-mass spectrometry. J. Chromatogr. B Biomed. Appl. 653:117-122.
8. DeMaula, C. D., M. A. Jutila, D. W. Wilson, and N. J. MacLachlan. 2001. Infection kinetics, prostacyclin release and cytokine-mediated modulation of the mechanism of cell death during bluetongue virus infection of cultured ovine and bovine pulmonary artery and lung microvascular endothelial cells. J. Gen. Virol. 82:787-794.
9. Galie, N., A. Manes, and A. Branzi. 2001. Medical therapy of pulmonary hypertension. The prostacyclins. Clin. Chest Med. 22:529-537.
10. Geraci, M. W., B. Gao, D. C. Shepherd, M. D. Moore, J. Y. Westcott, K. A. Fagan, L. A. Alger, R. M. Tuder, and N. F. Voelkel. 1999. Pulmonary prostacyclin synthase overexpression in transgenic mice protects against development of hypoxic pulmonary hypertension. J. Clin. Investig. 103:1509-1515.
11. Graham, B. S., L. A. Bunton, P. F. Wright, and D. T. Karzon. 1991. Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J. Clin. Investig. 88:1026-1033.
12. Graham, B. S., M. D. Perkins, P. F. Wright, and D. T. Karzon. 1988. Primary respiratory syncytial virus infection in mice. J. Med. Virol. 26:153-162.
13. Guidotti, L. G., and F. V. Chisari. 2001. Noncytolytic control of viral infections by the innate and adaptive immune response. Annu. Rev. Immunol. 19:65-91.
14. Hall, C. B. 2001. Respiratory syncytial virus and parainfluenza virus. N. Engl. J. Med. 344:1917-1928.
15. Jaflar, Z., K. S. Wan, and K. Roberts. 2002. A key role for prostaglandin I2 in limiting lung mucosal Th2, but not Th1, responses to inhaled allergen. J. Immunol. 169:5997-6004.
16. Keith, R. L., Y. E. Miller, Y. Hoshikawa, M. D. Moore, T. L. Gesell, B. Gao, A. M. Malkinson, H. A. Golpon, R. A. Nemenoff, and M. W. Geraci. 2002. Manipulation of pulmonary prostacyclin synthase expression prevents murine lung cancer. Cancer Res. 62:734-740.
17. Nagao, K., H. Tanaka, M. Komai, T. Masuda, S. Narumiya, and H. Nagai. 2003. Role of prostaglandin I2 in airway remodeling induced by repeated allergen challenge in mice. Am. J. Respir. Cell Mol. Biol. 29:314-320.
18. Narumiya, S., Y. Sugimoto, and F. Ushikubi. 1999. Prostanoid receptors: structures, properties, and functions. Physiol. Rev. 79:1193-1226.
19. Oh-ishi, S., I. Utsunomiya, T. Yamamoto, Y. Komuro, and Y. Hara. 1996. Effects of prostaglandins and cyclic AMP on cytokine production in rat leukocytes. Eur. J. Pharmacol. 300:255-259.
20. Pirich, C., Y. Efthimiou, J. O'Grady, C. Zielinski, and H. Sinzinger. 1996. Apolipoprotein A and biological half-life of prostaglandin I2 in HIV-1 infection. Thromb. Res. 81:213-218.
21. Shinomiya, S., H. Naraba, A. Ueno, I. Utsunomiya, T. Maruyama, S. Ohuchida, F. Ushikubi, K. Yuki, S. Narumiya, Y. Sugimoto, A. Ichikawa, and S. Oh-ishi. 2001. Regulation of TNFalpha and interleukin-10 production by prostaglandins I(2) and E(2): studies with prostaglandin receptor-deficient mice and prostaglandin E-receptor subtype-selective synthetic agonists. Biochem. Pharmacol. 61:1153-1160.
22. Smith, W. L., D. L. Dewitt, and R. M. Garavito. 2000. Cyclooxygenases: structural, cellular, and molecular biology. Annu. Rev. Biochem. 69:145-182.
23. Staat, M. A. 2002. Respiratory syncytial virus infections in children. Semin. Respir. Infect. 17:15-20.
24. Takahashi, Y., S. Tokuoka, T. Masuda, Y. Hirano, M. Nagao, H. Tanaka, N. Inagaki, S. Narumiya, and H. Nagal. 2002. Augmentation of allergic inflammation in prostanoid IP receptor deficient mice. Br. J. Pharmacol. 137:315-322.
25. van Schaik, S. M., N. Obot, G. Enhorning, K. Hintz, K. Gross, G. E. Hancock, A. M. Stack, and R. C. Welliver. 2000. Role of interferon gamma in the pathogenesis of primary respiratory syncytial virus infection in BALB/c mice. J. Med. Virol. 62:257-266.
26. Zavagno, G., B. Jaffe, and M. Esteban. 1987. Role of prostaglandins and non-steroid anti-inflammatory drugs in the pathogenicity of vaccinia virus. J. Gen. Virol. 68:593-600.